CP and COVID-19: Placebo-controlled clinical trials to test CP therapy are ongoing in China (NCT04264858), and larger studies also started in the USA (Houston Methodist Hospital, Houston, Texas; Mount Sinai Medical Center, New York, New York, etc.), after it was approved by the US Food and Drug Administration for COVID-19 treatment [59,60].